Related Experiment Video
Updated: Dec 9, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
COVID-19 and ESKD, A Rapid Review
Ankur D Shah1, Nathan Calabro-Kailukaitis2
1Alpert Medical School of Brown University, Providence, RI; Division of Kidney Disease and Hypertension, Rhode Island Hospital; Division of Nephrology, Medicine Service, Providence Veterans Affairs Medical Center, Providence, RI.
Abstract:
In 2020, the COVID-19 pandemic has ravaged the world. Individuals with end-stage kidney disease (ESKD) are at higher risk due to impaired immunity, comorbid conditions, and dependence on travel to medical care settings. We review the salient features of COVID-19 in this population, including the risk of infection, disease course, changes in dialysis unit management, use of investigatory medications, access considerations, home dialysis, and capacity planning.
More Related Videos
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations

